Compare CRI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRI | ALVO |
|---|---|---|
| Founded | 1865 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | 1460 |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2002 | N/A |
| Metric | CRI | ALVO |
|---|---|---|
| Price | $38.42 | $3.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $35.60 | $8.00 |
| AVG Volume (30 Days) | ★ 1.2M | 309.6K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.53 | N/A |
| Revenue | ★ $2,898,426,000.00 | N/A |
| Revenue This Year | $4.57 | $13.28 |
| Revenue Next Year | $1.12 | $18.63 |
| P/E Ratio | ★ $13.23 | $18.20 |
| Revenue Growth | ★ 1.91 | N/A |
| 52 Week Low | $23.38 | $3.03 |
| 52 Week High | $44.44 | $11.85 |
| Indicator | CRI | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 57.77 | 51.68 |
| Support Level | $31.90 | $3.03 |
| Resistance Level | $39.56 | $3.93 |
| Average True Range (ATR) | 1.81 | 0.17 |
| MACD | -0.24 | 0.02 |
| Stochastic Oscillator | 69.37 | 61.22 |
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.